Related Experiment Video

Updated: Aug 20, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Targeting promiscuous signaling pathways in cancer: another Notch in the bedpost

Levi J Beverly1, Anthony J Capobianco

  • 1The Wistar Institute, Molecular and Cellular Oncogenesis Program, 3601 Spruce Street, Philadelphia, PA 19104, USA.

Trends in Molecular Medicine
|November 30, 2004
PubMed

Insights

Chromosomal translocation and Ikaros mutations cooperate in T-cell acute lymphoblastic leukemia by disrupting normal gene regulation. This breakdown in coordinated repression and activation creates a pathway for leukemogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Chromosomal translocation t(7;9)(q34;q34.3) leads to constitutive Notch activation in T-cell acute lymphoblastic leukemia.
  • Ikaros mutations result in loss of DNA-binding and repressive activity.
  • These genetic alterations have been shown to cooperate in leukemogenesis.

Purpose of the Study:

  • To elucidate the cooperative mechanisms of t(7;9) and Ikaros mutations in T-cell acute lymphoblastic leukemia.
  • To investigate the disruption of transcriptional regulation by the combined mutations.
  • To identify potential therapeutic targets based on Notch signaling.

Main Methods:

  • Analysis of chromosomal translocations and gene mutations.
  • Investigation of transcription factor activity and DNA-binding.
  • Modeling of regulatory network disruption in leukemogenesis.

Main Results:

  • The combination of Ikaros loss-of-function and constitutive Notch activation disrupts the balance of gene repression and activation.
  • This disruption affects common regulatory elements, impacting multiple transcription factors.
  • The breakdown of coordinate transcriptional regulation is a key pathophysiological mechanism in leukemogenesis.

Conclusions:

  • Cooperation between t(7;9) translocation and Ikaros mutations drives T-cell acute lymphoblastic leukemia through dysregulated gene expression.
  • Disruption of coordinated transcriptional control at common regulatory elements is a critical event.
  • Notch signaling pathways present potential targets for novel therapeutic interventions.

More Related Videos

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...